News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
376,964 Results
Type
Article (23088)
Company Profile (134)
Press Release (353733)
Multimedia
Podcasts (42)
Webinars (14)
Section
Business (120659)
Career Advice (1167)
Deals (20371)
Drug Delivery (79)
Drug Development (34011)
Employer Resources (149)
FDA (6350)
Job Trends (8514)
News (182343)
Policy (13328)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1624)
Academic (2)
Accelerated approval (13)
Adcomms (17)
Allergies (41)
Alliances (27231)
ALS (83)
Alzheimer's disease (910)
Antibody-drug conjugate (ADC) (137)
Approvals (6547)
Artificial intelligence (298)
Autoimmune disease (66)
Automation (23)
Bankruptcy (132)
Best Places to Work (6628)
BIOSECURE Act (12)
Biosimilars (87)
Biotechnology (80)
Bladder cancer (77)
Brain cancer (21)
Breast cancer (272)
Cancer (2022)
Cardiovascular disease (202)
Career advice (1029)
Career pathing (38)
CAR-T (147)
CDC (20)
Cell therapy (376)
Cervical cancer (14)
Clinical research (28668)
Collaboration (946)
Compensation (485)
Complete response letters (19)
COVID-19 (1172)
CRISPR (55)
C-suite (630)
Cystic fibrosis (77)
Data (2907)
Decentralized trials (1)
Denatured (24)
Depression (62)
Diabetes (208)
Diagnostics (3772)
Digital health (23)
Diversity (11)
Diversity, equity & inclusion (40)
Drug discovery (140)
Drug pricing (69)
Drug shortages (6)
Duchenne muscular dystrophy (105)
Earnings (50056)
Editorial (24)
Employer branding (23)
Employer resources (130)
Events (61233)
Executive appointments (741)
FDA (7800)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (12)
Funding (904)
Gene editing (100)
Generative AI (31)
Gene therapy (259)
GLP-1 (494)
Government (1682)
Guidances (260)
Healthcare (8727)
HIV (35)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (83)
Immuno-oncology (14)
Indications (42)
Infectious disease (1287)
Inflammatory bowel disease (99)
Inflation Reduction Act (8)
Influenza (44)
Intellectual property (84)
Interviews (159)
IPO (9915)
IRA (17)
Job creations (2087)
Job search strategy (889)
JPM (28)
Kidney cancer (11)
Labor market (81)
Layoffs (271)
Leadership (22)
Legal (3281)
Liver cancer (43)
Longevity (11)
Lung cancer (249)
Lymphoma (198)
Machine learning (20)
Management (46)
Manufacturing (386)
MASH (75)
Medical device (5919)
Medtech (5942)
Mergers & acquisitions (11123)
Metabolic disorders (543)
Multiple sclerosis (82)
NASH (14)
Neurodegenerative disease (152)
Neuropsychiatric disorders (31)
Neuroscience (1524)
Neurotech (1)
NextGen: Class of 2026 (3253)
Non-profit (2163)
Now hiring (64)
Obesity (259)
Opinion (146)
Ovarian cancer (54)
Pain (89)
Pancreatic cancer (79)
Parkinson's disease (129)
Partnered (23)
Patents (145)
Patient recruitment (189)
Peanut (20)
People (41122)
Pharmaceutical (31)
Pharmacy benefit managers (4)
Phase 1 (8444)
Phase 2 (12081)
Phase 3 (10685)
Pipeline (2980)
Policy (114)
Postmarket research (1070)
Preclinical (4010)
Press Release (71)
Prostate cancer (106)
Psychedelics (28)
Radiopharmaceuticals (151)
Rare diseases (395)
Real estate (3667)
Recruiting (60)
Regulatory (10176)
Reports (52)
Research institute (1433)
Resumes & cover letters (164)
Rett syndrome (20)
RNA editing (9)
RSV (43)
Schizophrenia (90)
Series A (155)
Series B (120)
Service/supplier (7)
Sickle cell disease (47)
Special edition (10)
Spinal muscular atrophy (80)
Sponsored (18)
Startups (2480)
State (1)
Stomach cancer (6)
Supply chain (46)
Tariffs (19)
The Weekly (17)
Vaccines (358)
Venture capital (62)
Weight loss (151)
Women's health (40)
Worklife (18)
Date
Last 7 days (300)
Last 30 days (1144)
Last 365 days (15912)
2026 (1509)
2025 (16180)
2024 (19286)
2023 (22384)
2022 (29001)
2021 (31427)
2020 (29330)
2019 (24123)
2018 (17949)
2017 (17371)
2016 (16667)
2015 (19760)
2014 (15397)
2013 (12626)
2012 (13647)
2011 (14231)
2010 (13794)
Location
Africa (447)
Alabama (42)
Alaska (5)
Arizona (144)
Arkansas (4)
Asia (20364)
Australia (3255)
California (5816)
Canada (1910)
China (427)
Colorado (260)
Connecticut (246)
Delaware (219)
Europe (47646)
Florida (871)
Georgia (142)
Hawaii (2)
Idaho (30)
Illinois (337)
India (40)
Indiana (350)
Iowa (19)
Japan (266)
Kansas (61)
Kentucky (24)
Louisiana (14)
Maine (57)
Maryland (571)
Massachusetts (4580)
Michigan (186)
Minnesota (341)
Mississippi (5)
Missouri (70)
Montana (19)
Nebraska (20)
Nevada (60)
New Hampshire (27)
New Jersey (1701)
New Mexico (20)
New York (1671)
North Carolina (895)
North Dakota (9)
Northern California (2968)
Ohio (194)
Oklahoma (11)
Oregon (20)
Pennsylvania (1015)
Puerto Rico (7)
Rhode Island (29)
South America (591)
South Carolina (24)
Southern California (2129)
Tennessee (105)
Texas (806)
United States (21089)
Utah (153)
Vermont (1)
Virginia (143)
Washington D.C. (45)
Washington State (478)
West Virginia (3)
Wisconsin (95)
Wyoming (1)
376,964 Results for "apnea sciences corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Apnimed Announces Publication in The Lancet of Positive Phase 2 Results Demonstrating Sulthiame’s Efficacy in Obstructive Sleep Apnea
November 3, 2025
·
6 min read
Press Releases
Apnimed To Present Additional Phase 3 Data for AD109, an Investigational Oral Pill for Obstructive Sleep Apnea, at CHEST 2025 Annual Meeting
October 20, 2025
·
9 min read
Press Releases
Mineralys Therapeutics Completes Enrollment in Phase 2 EXPLORE-OSA Trial of Lorundrostat in Obstructive Sleep Apnea and Hypertension
October 1, 2025
·
8 min read
Press Releases
Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment
September 18, 2025
·
6 min read
Press Releases
Nylon flexTAP®: First FDA cleared 3D-Printed Midline Oral Appliance for Sleep Apnea
September 18, 2025
·
3 min read
Press Releases
Apnimed to Highlight AD109 and the Burden of Obstructive Sleep Apnea (OSA) at World Sleep Congress 2025
September 4, 2025
·
5 min read
GLP-1
Lilly’s Zepbound Snags First Ever Sleep Apnea Drug Approval
The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in combination with diet and exercise.
December 23, 2024
·
2 min read
·
Kate Goodwin
Press Releases
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea
August 8, 2025
·
6 min read
Press Releases
Science Corporation Names Darius Shahida as Chief Strategy Officer
December 12, 2025
·
3 min read
Press Releases
Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives
A new survey conducted by Quantum Research Group, LLC finds that more than half of patients diagnosed with sleep apnea are not satisfied with their current treatment. Nearly 70 percent of patients express a willingness to switch to a prescribed pill-form treatment.
September 9, 2024
·
4 min read
1 of 37,697
Next
